Bjorn Lennart Dahlof (Björn Dahllöf)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Arterial Hypertension

Top Venues

Scandinavian journal of primary health care

Cereno Scientific AB

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cereno Scientific AB Aug 01 2018

Sweden

CMO

Publications

Livia Stanger, Adriana Yamaguchi, Pooja Yalavarthi, Sylviane Lambert, Devin Gilmore, Andrew Rickenberg, Catherine Luke, Kiran Kumar, Andrea Tara Obi, Andrew White, Niklas Berg, Bjorn Lennart Dahlof, Michael A Holinstat
The oxylipin analogue CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor. Blood (2023)
Mikael Hoffmann, Peter M Nilssson, Johan Ahlner, Bjorn Lennart Dahlof, Mats Fredrikson, Roger Säljö, Karin I Kjellgren
Do patients or their physicians more accurately assess long-term risk associated with hypertension? A population-based study. Scandinavian journal of primary health care 38 (2) (2020)